FindTrial
Sign In

A study to explore clinical characteristics and survival of patients with N2 non-small cell lung cancer complicated with lymph skip metastases

A multi-centre real-world observational study to explore clinical characteristics and survival of patients with N2 non-small cell lung cancer complicated with lymph skip metastases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014729
Enrollment
Unknown
Registered
2018-01-31
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Case series:Surgeries

Sponsors

Tianjin Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with lung surgeries who were enrolled in clinics from 2014 to 2017; 2. Pathologically diagnosed patients with non-small cell lung cancer; 3. Patients with age>18 years; 4. Patients who were previously performed with chest surgeries before hospitalization; 5. Patients with N2 lymph nodes after surgeries and lymphadenectomy (Group 10 and 11 lymph nodes).

Exclusion criteria

Exclusion criteria: Patients who received radiotherapies, chemotherapies, and biological therapies for tumors.

Design outcomes

Primary

MeasureTime frame
Differences in overall survivals (in the subgroups of lymph skip metastases and non-lymph skip metastases;—

Secondary

MeasureTime frame
Differences in disease-free survivals (in the subgroups of lymph skip metastases and non-lymph skip metastases);—

Countries

China

Contacts

Public ContactXun Zhang

Tianjin Chest Hospital

zhangxun69@163.com+86 18602212679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026